"As a provider of leading-edge RFID security solutions, we consider the ASIS International conference a key event for us, as it gives us the perfect opportunity to showcase our patented implantable technology and the related security applications," said Kevin McLaughlin, Chief Executive Officer of VeriChip Corporation. "To those wishing to see the latest in RFID security solutions - including applications using implantable, wearable, and attachable RFID tag technology - we extend the invitation to visit the VeriChip booth at ASIS."
In October 2004 VeriChip received FDA clearance to market its human-implantable RFID microchip for medical applications. About the size of a grain of rice, the chip is inserted just under the skin. With its unique 16-bit electronic ID, the chip can be used in such applications as patient identification in emergency departments or for access control in high-security areas. Unlike conventional forms of identification, the chip cannot be lost, stolen, or duplicated, ensuring a level of identification and protection never possible before.
At the ASIS show, VeriChip Corporation will be demonstrating its chip technology integrated with its security application, VeriGuard. VeriGuard, a featured new product by ASIS this year, provides individual location and distress alert capability, access control, and asset tracking for the identification, location, and protection of individuals and assets. VeriChip's market-leading infant protection and wander prevention solutions will also be on display.
For more information, please call 1.800.970.CHIP, email email@example.com, or visit www.verichipcorp.com. VeriChip will be at booth #4488 at the ASIS International conference, which takes place September 12-15, 2005 in Orlando, Florida.
ASIS International, with more than 33,000 members, is the preeminent international organization for professionals responsible for security, including managers and directors of security. For more information, please visit http://www.asisonline.org.
About VeriChip - "RFID for people"
VeriChip is a subsidiary of Applied Digital and provides state-of-the-art RFID security solutions that identify, locate, and protect people, their assets, and their environments. From the world's first and only FDA-cleared, human-implantable RFID microchip to the only active RFID tag with patented skin sensing capabilities, VeriChip's technology ensures the safety and security organizations are looking for. Its market-leading infant protection, wander prevention, asset tracking, and patient identification applications make VeriChip the predominant RFID solutions provider in the healthcare industry. And today, VeriChip systems are installed in over 4,000 locations worldwide in healthcare, security, industrial, and government markets making it the world's premier RFID company for people. For more information on VeriChip, please visit www.verichipcorp.com.
About Applied Digital - "The Power of Identification Technology"
Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The Company's unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as the leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (AMEX:DOC).
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.